Trial intelligence / Profile preview

Clindamycin pharmacokinetics in overweight hospitalized adults

NL-OMON45669Recruiting

Sponsor
Gelre ziekenhuizen
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of clindamycin in bacterial disease, sponsored by Gelre ziekenhuizen. Primary endpoints: Population pharmacokinetic model, Clearance and 1 more. Started Jan 2018; status: recruiting.

02

Drugs

clindamycin
03

Conditions

bacterial disease

Beyond the preview

Go deeper on NL-OMON45669.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON45669.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call